ODT’s Most-Read Stories This Week—June 10

Patient-specific 3D technology, natural bone healing, and virtual reality were the topics of choice this week on ODT’s website.

Cybervisitors were most interested in Treace Medical Concepts’ purchase of patient-specific instrumentation technology, and an online exclusive aboout patient-specific cutting guides designs. The latter story detailed the guides’ uses to date, and a working collaboration between Synopsys and nTop to produce custom designed workflows utilizing AI-based machine learning tools in Simpleware software, and nTop’s design automation capabilities. Test workflows are already demonstrating promising results for quickly and accurately using patient data to create surgical cutting guides. 

Treace Medical Concepts, meanwhile, garnered the most pageviews for announcing a purchase agreement to acquire assets of MIOS Marketing d/b/a RedPoint Medical3D (RPM 3D), a company that offers pre-op planning and patient-specific guides to be used in surgical correction of deformities customized to unique foot anatomy. The purchase price is $20 million in upfront cash payment, with up to $10 million in possible milestone payments. Using CT scan data, RPM-3D uses software to develop a 3D pre-op plan to correct the patient’s deformity and produce a 3D-printed, patient-specific cut guide. RPM-3D software and systems with be combined with Treace’s instrumentation and implant systems this year, with commercial release of patient-specific products anticipated in the second half of 2024.

Another acquisition that drove considerable site traffic was Biocomposites’ purchase of bone graft substitute manufacturer Artoss GmbH. Artoss offers a range of bone graft substitutes using its proprietary NanoBone technology, which is a combination of nanocrystalline hydroxyapatite and silica gel. NanoBone aims to provide optimal bone formation with easy handling. NanoBone’s special structure activates the body’s bone-forming forces and, according to Biocomposites, leads to very rapid bone healing. In addition to the company’s lead product NanoBone SBX putty, the company has a range of indication-specific product variants that are all ready to use directly from their applicators. 

Osso VR appealed to the internet masses this past week by launching Osso Academy, a comprehensive virtual reality (VR) training program tailored for academic medical centers and residency programs. Developed in collaboration with world-renowned surgeons and medical educators, Osso Academy offers an extensive curriculum built on leading-edge simulation technology to provide continuous hands-on training and assessment on demand. Osso Academy is an expansion of an existing offering to teaching hospitals and a natural extension of the company’s mission to democratize access to surgical training worldwide. The Academy is debuting at a time when VR is becoming widely accepted and advocated by medical facilities and professionals. According to data from Accenture, 82% of healthcare professionals agree that VR creates a convenient way of accessing and learning information for medical students and practicing healthcare professionals.

1. Treace to Buy RPM-3D Tech for Up to $30 Million

2. Designing Scalable Patient-Specific Cutting Guides

3. Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer

4. Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute

5. Osso VR Launches Virtual Reality Training Program